Diacerein-Loaded novel gastroretentive nanofiber system using PLLA: Development and in vitro characterization
Source abstract
Abstract
The purpose of this research is to describe the utility of nanofibers as a gastroretentive dosage form and improve the solubility of diacerein (DIA) by using the above approach. Poly L-(lactic acid) (PLLA) nanofibers loaded with DIA were prepared using the electrospinning technique. The nanofibers developed were characterized for morphology, tensile strength, floating behavior, drug entrapment, drug solubility, mucoadhesive detachment force, and drug release profile. The results demonstrated that the drug-loaded nanofibers were smooth, discrete, & non-woven. Analysis by X-ray crystallography (XRD) revealed that the drug in the nanofiber was present in the amorphous state, which largely contributes to higher drug solubility in the nanofibers developed. The buoyancy study demonstrated that the nanofibers developed exhibited zero lag time. Approximately 61.3% of drug was released in 30 h, thus facilitating the slow release of the drug from the nanofiber system. Finally, we concluded that the electrospun nanofibers developed offer a promising gastroretentive drug delivery system to deliver DIA with improved solubility.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Hydrogels: synthesis, properties, applications · Advanced Drug Delivery Systems
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
,
References (59)
Show source-provided references
1. 10.1016/j.compscitech.2010.01.01010.1016/j.compscitech.2010.01.010 ↗
2. Chaudhary S, Garg T, Murthy RS, Rath G, Goyal AK. 2014. Recent approaches of lipid-based delivery system for lymphatic targeting via oral route. J Drug Target. 1–12.
3. 10.1088/0957-4484/17/15/04510.1088/0957-4484/17/15/045 ↗
4. 10.1016/j.ejps.2013.11.01610.1016/j.ejps.2013.11.016 ↗
5. 10.4314/tjpr.v7i3.1469110.4314/tjpr.v7i3.14691 ↗
6. 10.3109/21691401.2014.91671510.3109/21691401.2014.916715 ↗
7. 10.2174/2210304x1120204000510.2174/2210304x11202040005 ↗
8. 10.1517/17425247.2014.89101410.1517/17425247.2014.891014 ↗
9. 10.2174/2210303111303666001510.2174/22103031113036660015 ↗
10. 10.2174/2210304x1120204000310.2174/2210304x11202040003 ↗
11. 10.1615/CritRevTherDrugCarrierSyst.201401110410.1615/CritRevTherDrugCarrierSyst.2014011104 ↗
12. 10.1615/CritRevTherDrugCarrierSyst.201401012210.1615/CritRevTherDrugCarrierSyst.2014010122 ↗
13. Garg T, Rath G, Goyal AK. 2014c. Comprehensive review on additives of topical dosage forms for drug delivery. Drug Deliv.
14. Garg T, Singh O, Arora S, Murthy R. 2011a. Dendrimer—A novel scaffold for drug delivery. Int J Pharm Sci Rev Res. 7:211–220.
15. Garg T, Singh O, Arora S, Murthy R. 2011b. Patented microencapsulation techniques and its application. J Pharm Res. 4:2097–2102.
16. 10.1615/CritRevTherDrugCarrierSyst.v29.i1.1010.1615/CritRevTherDrugCarrierSyst.v29.i1.10 ↗
17. 10.1615/CritRevTherDrugCarrierSyst.201300725910.1615/CritRevTherDrugCarrierSyst.2013007259 ↗
18. Goyal AK, Rath G, Garg T. 2013a. Nanotechnological approaches for genetic immunization. DNA and RNA Nanobiotechnologies In Medicine: Diagnosis And Treatment Of Diseases. Erdmann, Volker A., Barciszewski, hab. Jan (Eds.). Springer-Verlag Berlin Heidelberg, pp. 67–120.10.1007/978-3-642-36853-0_4 ↗
19. Goyal G, Garg T, Malik B, Chauhan G, Rath G, Goyal AK. 2013b. Development and characterization of niosomal gel for topical delivery of benzoyl peroxide. Drug Deliv.
20. 10.1615/CritRevTherDrugCarrierSyst.201400811710.1615/CritRevTherDrugCarrierSyst.2014008117 ↗
21. 10.1615/CritRevTherDrugCarrierSyst.201401012310.1615/CritRevTherDrugCarrierSyst.2014010123 ↗
22. Grainger SJ, El-Sayed MEH. 2010. Stimuli-Sensitive particles for drug delivery. In: Jabbari E, Khademhosseini A, Eds. Biologically-Responsive Hybrid Biomaterials. Singapore: World Scientific, pp. 171–190.10.1142/9789814295680_0008 ↗
23. 10.1166/jbt.2014.121410.1166/jbt.2014.1214 ↗
24. 10.2174/15672010777931473010.2174/156720107779314730 ↗
25. 10.3109/10717544.2014.92876010.3109/10717544.2014.928760 ↗
26. 10.3109/10717544.2014.93553110.3109/10717544.2014.935531 ↗
27. 10.3109/21691401.2014.98430310.3109/21691401.2014.984303 ↗
28. 10.2174/2210303111303666001810.2174/22103031113036660018 ↗
29. 10.3109/21691401.2014.98430210.3109/21691401.2014.984302 ↗
30. 10.1615/CritRevTherDrugCarrierSyst.201400828510.1615/CritRevTherDrugCarrierSyst.2014008285 ↗
31. Kaur M, Malik B, Garg T, Rath G, Goyal AK. 2014c. Development and characterization of guar gum nanoparticles for oral immunization against tuberculosis. Drug Deliv.
32. 10.3109/10717544.2014.99348610.3109/10717544.2014.993486 ↗
33. 10.3109/10717544.2014.99348610.3109/10717544.2014.993486 ↗
34. 10.3109/21691401.2014.98430210.3109/21691401.2014.984302 ↗
35. 10.1615/CritRevTherDrugCarrierSyst.201401052710.1615/CritRevTherDrugCarrierSyst.2014010527 ↗
36. 10.3109/1061186X.2014.94729510.3109/1061186X.2014.947295 ↗
37. 10.3109/1061186X.2014.96571510.3109/1061186X.2014.965715 ↗
38. 10.3109/10717544.2014.93553210.3109/10717544.2014.935532 ↗
39. 10.1016/j.colsurfb.2010.12.02210.1016/j.colsurfb.2010.12.022 ↗
40. 10.3109/21691401.2014.92400710.3109/21691401.2014.924007 ↗
41. 10.3109/21691401.2014.92787910.3109/21691401.2014.927879 ↗
42. 10.3109/21691401.2014.96619510.3109/21691401.2014.966195 ↗
43. Pillay V, Dott C, Choonara YE, Tyagi C, Tomar L, Kumar P, et al. 2013. A review of the effect of processing variables on the fabrication of electrospun nanofibers for drug delivery applications. J Nanomater.
44. 10.3109/10717544.2014.94501810.3109/10717544.2014.945018 ↗
45. 10.3109/10717544.2014.94501810.3109/10717544.2014.945018 ↗
46. 10.4103/0250-474X.4033010.4103/0250-474X.40330 ↗
47. Sharma A, Garg T, Aman A, Panchal K, Sharma R, Kumar S, Markandeywar T. 2014a. Nanogel-an advanced drug delivery tool: current and future. Artif Cells Nanomed Biotechnol. 1–13.
48. Sharma R, Garg T, Goyal AK, Rath G. 2014b. Development, optimization and evaluation of polymeric electrospun nanofiber: a tool for local delivery of fluconazole for management of vaginal candidiasis. Artif Cells Nanomed Biotechnol. 1–8.
49. 10.1615/CritRevTherDrugCarrierSyst.201400819310.1615/CritRevTherDrugCarrierSyst.2014008193 ↗
50. Singh B, Garg T, Goyal AK, Rath G. 2014a. Recent advancements in the cardiovascular drug carriers. Artif Cells Nanomed Biotechnol. 1–10.
51. Singh H, Sharma R, Joshi M, Garg T, Goyal AK, Rath G. 2014b. Transmucosal delivery of Docetaxel by mucoadhesive polymeric nanofibers. Artificial Cells Nanomed Biotechnol. 1–7.
52. Singh K, Arora N, Garg T. 2012a. RFID: a trustable security tool in pharmaceutical industry. Am J Pharm Tech Res. 2:113–127.
53. Singh K, Arora N, Garg T. 2012b. Superbug: Antimicrobial resistance due to NDM-1. IJIPLS. 2:58–66.
54. 10.1155/2014/35242510.1155/2014/352425 ↗
55. 10.1016/j.ejpb.2007.03.01810.1016/j.ejpb.2007.03.018 ↗
56. Wade A, Weller PJ. 1994. Handbook of pharmaceutical excipients, Washington: American Pharmaceutical association, London: pharmaceutical press.
57. 10.1016/j.eurpolymj.2006.03.03210.1016/j.eurpolymj.2006.03.032 ↗
58. 10.4236/health.2009.1201210.4236/health.2009.12012 ↗
59. Yu D, Zhang X, Shen X, Branford-White C, Zhu LM. 2009b. [The improvement of poorly water-soluble drug solubility through electrospun drug-loaded nanofibers]. Yao Xue Xue Bao = Acta pharmaceutica Sinica. 44:1179–1182.